How Effective Is the Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) in Different Patient Populations, and When Should It Be Used in Clinical Practice?

The efficacy and safety of the fixed-ratio combination of insulin degludec (degludec) and liraglutide (IDegLira) were confirmed in the DUAL clinical trial program, in which IDegLira demonstrated superior or noninferior glycemic control over comparators in addition to its low risks of hypoglycemia an...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Diabetes
Hlavní autoři: Tibaldi, Joseph, Mercado, Max E., Strong, Jodi
Médium: Artigo
Jazyk:Inglês
Vydáno: American Diabetes Association 2020
Témata:
Feature Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7566936/
https://ncbi.nlm.nih.gov/pubmed/33132503
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/cd20-0014
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky